TY  - JOUR

T1  - INVEST: A phase Ib window of opportunity study of atezolizumab administered either intravesically or direct tumour injection in patients with bladder cancer prior to radical cystectomy.

JO  - Journal of Clinical Oncology

UR  - http://dx.doi.org/10.1200/jco.2024.42.4_suppl.tps710

PY  - 2024/01/29

AU  - Hussain SA

AU  - Oughton JB

AU  - Smith Whelan R

AU  - Green A

AU  - Hubbard R

AU  - Kennish S

AU  - Senior E

AU  - Kendall J

AU  - McCready D

AU  - Collinson FJ

AU  - Griffin J et al

ED  - 

DO  - DOI: 10.1200/jco.2024.42.4_suppl.tps710

PB  - American Society of Clinical Oncology (ASCO)

VL  - 42

IS  - 4_suppl

SP  - TPS710

EP  - TPS710

Y2  - 2024/12/22

ER  -